Patients treated with mogamulizumab showed a trend toward improved OS compared to those not receiving mogamulizumab across risk-stratified groups according to the new Cutaneous Lymphoma International ...
Our growth is driven by our customers’ success,” said Rick Faulk, CEO of Locus Robotics. “Retailers, 3PLs, and healthcare providers are seeing measurable impact faster than ever—scaling productivity ...
This collaboration connects two technologies, Smartstream’s Smart Collateral with ActiveViam’s Atoti Collateral Optimisation solution. The result is an efficient, streamlined and cost-effective ...
Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent Biologics (HKEX: 01801) for the development, manufacturing and commercialization ...
Enterprises across the Asia Pacific region are rapidly incorporating AI into their application development and maintenance (ADM) operations, changing how applications are built, tested and maintained, ...
| SpaceX says 'disabled' 2,500 Starlink devices at Myanmar scam centres ...
This milestone reflects the company’s deepening commitment to the Japanese market and marks a significant step in enhancing ...
Biedermann Motech will showcase the worldwide first MOSS!MODULARITY Injection Screw and the DELTA XS 2.0 Retractor System at ...
(NYSE: LAZ) today announced the appointment of Edouard Panié as Managing Director and Co-Head of the European Financial ...
SRB5 is a humanized monoclonal antibody with enhanced ADCC properties, designed to selectively deplete CCR9+ cells involved in chronic intestinal inflammation. It is the latest advancement in ...
For 2026, Omdia expects AMOLED revenues to reach $56 billion, a 5% year-over-year (YoY) growth from 2025. Key driving factors such as LTPO smartphone, OLED mobile PC panels and the 65-inch to 83-inch ...
For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction. 1,2 Yet from today, the UK’s first needle-free ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results